686 related articles for article (PubMed ID: 27381525)
41. Controlled-release kinetics and biologic activity of platelet-derived growth factor-BB for use in flexor tendon repair.
Sakiyama-Elbert SE; Das R; Gelberman RH; Harwood F; Amiel D; Thomopoulos S
J Hand Surg Am; 2008 Nov; 33(9):1548-57. PubMed ID: 18984337
[TBL] [Abstract][Full Text] [Related]
42. Zeaxanthin inhibits PDGF-BB-induced migration in human dermal fibroblasts.
Wu NL; Chiang YC; Huang CC; Fang JY; Chen DF; Hung CF
Exp Dermatol; 2010 Aug; 19(8):e173-81. PubMed ID: 20482615
[TBL] [Abstract][Full Text] [Related]
43. [Experimental study on recombinant human platelet-derived growth factor gel in a diabetic rat model of cutaneous incisal wound healing].
Sun TZ; Fu XB; Zhao ZL; Chen W; Sun XQ; Zhou G; Shen ZY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Oct; 15(10):596-9. PubMed ID: 14552680
[TBL] [Abstract][Full Text] [Related]
44. Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression.
Tkalcević VI; Cuzić S; Brajsa K; Mildner B; Bokulić A; Situm K; Perović D; Glojnarić I; Parnham MJ
Eur J Pharmacol; 2007 Sep; 570(1-3):212-21. PubMed ID: 17628536
[TBL] [Abstract][Full Text] [Related]
45. Heparin-conjugated poly(lactic-co-glycolic acid) nanospheres enhance large-wound healing by delivering growth factors in platelet-rich plasma.
La WG; Yang HS
Artif Organs; 2015 Apr; 39(4):388-94. PubMed ID: 25284020
[TBL] [Abstract][Full Text] [Related]
46. Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells.
Lederle W; Stark HJ; Skobe M; Fusenig NE; Mueller MM
Am J Pathol; 2006 Nov; 169(5):1767-83. PubMed ID: 17071599
[TBL] [Abstract][Full Text] [Related]
47. Tissue localization of beta receptors for platelet-derived growth factor and platelet-derived growth factor B chain during wound repair in humans.
Reuterdahl C; Sundberg C; Rubin K; Funa K; Gerdin B
J Clin Invest; 1993 May; 91(5):2065-75. PubMed ID: 8486774
[TBL] [Abstract][Full Text] [Related]
48. Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis.
Asai J; Takenaka H; Hirakawa S; Sakabe J; Hagura A; Kishimoto S; Maruyama K; Kajiya K; Kinoshita S; Tokura Y; Katoh N
Am J Pathol; 2012 Dec; 181(6):2217-24. PubMed ID: 23138019
[TBL] [Abstract][Full Text] [Related]
49. Human corneal fibroblast migration and extracellular matrix synthesis during stromal repair: Role played by platelet-derived growth factor-BB, basic fibroblast growth factor, and transforming growth factor-β1.
Gallego-Muñoz P; Ibares-Frías L; Garrote JA; Valsero-Blanco MC; Cantalapiedra-Rodríguez R; Merayo-Lloves J; Carmen Martínez-García M
J Tissue Eng Regen Med; 2018 Feb; 12(2):e737-e746. PubMed ID: 27860426
[TBL] [Abstract][Full Text] [Related]
50. Combined effects of PLGA and vascular endothelial growth factor promote the healing of non-diabetic and diabetic wounds.
Chereddy KK; Lopes A; Koussoroplis S; Payen V; Moia C; Zhu H; Sonveaux P; Carmeliet P; des Rieux A; Vandermeulen G; Préat V
Nanomedicine; 2015 Nov; 11(8):1975-84. PubMed ID: 26238081
[TBL] [Abstract][Full Text] [Related]
51. Interleukin-6 stimulates Akt and p38 MAPK phosphorylation and fibroblast migration in non-diabetic but not diabetic mice.
Nishikai-Yan Shen T; Kanazawa S; Kado M; Okada K; Luo L; Hayashi A; Mizuno H; Tanaka R
PLoS One; 2017; 12(5):e0178232. PubMed ID: 28542434
[TBL] [Abstract][Full Text] [Related]
52. PDGF-BB released in tendon repair using a novel delivery system promotes cell proliferation and collagen remodeling.
Thomopoulos S; Zaegel M; Das R; Harwood FL; Silva MJ; Amiel D; Sakiyama-Elbert S; Gelberman RH
J Orthop Res; 2007 Oct; 25(10):1358-68. PubMed ID: 17551975
[TBL] [Abstract][Full Text] [Related]
53. Identification of the critical therapeutic entity in secreted Hsp90α that promotes wound healing in newly re-standardized healthy and diabetic pig models.
O'Brien K; Bhatia A; Tsen F; Chen M; Wong AK; Woodley DT; Li W
PLoS One; 2014; 9(12):e113956. PubMed ID: 25464502
[TBL] [Abstract][Full Text] [Related]
54. Regulation of impaired angiogenesis in diabetic dermal wound healing by microRNA-26a.
Icli B; Nabzdyk CS; Lujan-Hernandez J; Cahill M; Auster ME; Wara AK; Sun X; Ozdemir D; Giatsidis G; Orgill DP; Feinberg MW
J Mol Cell Cardiol; 2016 Feb; 91():151-9. PubMed ID: 26776318
[TBL] [Abstract][Full Text] [Related]
55. PDGF supplementation alters oxidative events in wound healing process: a time course study.
Kaltalioglu K; Coskun-Cevher S; Tugcu-Demiroz F; Celebi N
Arch Dermatol Res; 2013 Jul; 305(5):415-22. PubMed ID: 23423159
[TBL] [Abstract][Full Text] [Related]
56. Preparation and in vivo evaluation of cationic elastic liposomes comprising highly skin-permeable growth factors combined with hyaluronic acid for enhanced diabetic wound-healing therapy.
Choi JU; Lee SW; Pangeni R; Byun Y; Yoon IS; Park JW
Acta Biomater; 2017 Jul; 57():197-215. PubMed ID: 28476587
[TBL] [Abstract][Full Text] [Related]
57. Diabetic wound regeneration using peptide-modified hydrogels to target re-epithelialization.
Xiao Y; Reis LA; Feric N; Knee EJ; Gu J; Cao S; Laschinger C; Londono C; Antolovich J; McGuigan AP; Radisic M
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):E5792-E5801. PubMed ID: 27647919
[TBL] [Abstract][Full Text] [Related]
58. Effect of herbal mixture composed of Alchemilla vulgaris and Mimosa on wound healing process.
Choi J; Park YG; Yun MS; Seol JW
Biomed Pharmacother; 2018 Oct; 106():326-332. PubMed ID: 29966977
[TBL] [Abstract][Full Text] [Related]
59. Growth factors in clinical practice.
Köveker GB
Int J Clin Pract; 2000 Nov; 54(9):590-3. PubMed ID: 11220987
[TBL] [Abstract][Full Text] [Related]
60. Priming with a combination of proangiogenic growth factors enhances wound healing in streptozotocin-induced diabetes in mice.
Ackermann M; Wolloscheck T; Wellmann A; Li VW; Li WW; Konerding MA
Eur Surg Res; 2011; 47(2):81-9. PubMed ID: 21720165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
